{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:37:37Z","timestamp":1790537857429,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T00:00:00Z","timestamp":1350432000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1038\/ejhg.2012.222","type":"journal-article","created":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T10:40:59Z","timestamp":1350470459000},"page":"643-652","source":"Crossref","is-referenced-by-count":66,"title":["Severe SMA mice show organ impairment that cannot be rescued by therapy with the HDACi JNJ-26481585"],"prefix":"10.1038","volume":"21","author":[{"given":"Julia","family":"Schreml","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Riessland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Paterno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Garbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Ro\u00dfbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastian","family":"Ackermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eilidh","family":"Somers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon H","family":"Parson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albrecht","family":"Berkessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Sterner-Kock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brunhilde","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,17]]},"reference":[{"key":"BFejhg2012222_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","volume":"3","author":"TO Crawford","year":"1996","unstructured":"Crawford TO, Pardo CA : The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis 1996; 3: 97\u2013110.","journal-title":"Neurobiol Dis"},{"key":"BFejhg2012222_CR2","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/338627","volume":"70","author":"M Feldkotter","year":"2002","unstructured":"Feldkotter M, Schwarzer V, Wirth R, Wienker TF, Wirth B : Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 2002; 70: 358\u2013368.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2012222_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/BF00212036","volume":"93","author":"A Thieme","year":"1994","unstructured":"Thieme A, Mitulla B, Schulze F, Spiegler AW : Chronic childhood spinal muscular atrophy in Germany (West-Thuringen)--an epidemiological study. Hum Genet 1994; 93: 344\u2013346.","journal-title":"Hum Genet"},{"key":"BFejhg2012222_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, Burglen L, Reboullet S et al: Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995; 80: 155\u2013165.","journal-title":"Cell"},{"key":"BFejhg2012222_CR5","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","volume":"15","author":"B Wirth","year":"2000","unstructured":"Wirth B : An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat 2000; 15: 228\u2013237.","journal-title":"Hum Mutat"},{"key":"BFejhg2012222_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00439-008-0598-1","volume":"125","author":"L Alias","year":"2009","unstructured":"Alias L, Bernal S, Fuentes-Prior P et al: Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene. Hum Genet 2009; 125: 29\u201339.","journal-title":"Hum Genet"},{"key":"BFejhg2012222_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","volume":"2","author":"TL Munsat","year":"1992","unstructured":"Munsat TL, Davies KE : International SMA consortium meeting. (26\u201328 June 1992, Bonn, Germany). Neuromuscul Disord 1992; 2: 423\u2013428.","journal-title":"Neuromuscul Disord"},{"key":"BFejhg2012222_CR8","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1086\/515465","volume":"60","author":"PE McAndrew","year":"1997","unstructured":"McAndrew PE, Parsons DW, Simard LR et al: Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet 1997; 60: 1411\u20131422.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2012222_CR9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00439-006-0156-7","volume":"119","author":"B Wirth","year":"2006","unstructured":"Wirth B, Brichta L, Schrank B et al: Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Hum Genet 2006; 119: 422\u2013428.","journal-title":"Hum Genet"},{"key":"BFejhg2012222_CR10","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/ng1207","volume":"34","author":"T Kashima","year":"2003","unstructured":"Kashima T, Manley JL : A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat Genet 2003; 34: 460\u2013463.","journal-title":"Nat Genet"},{"key":"BFejhg2012222_CR11","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"CL Lorson","year":"1999","unstructured":"Lorson CL, Hahnen E, Androphy EJ, Wirth B : A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA 1999; 96: 6307\u20136311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg2012222_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/ng854","volume":"30","author":"L Cartegni","year":"2002","unstructured":"Cartegni L, Krainer AR : Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 2002; 30: 377\u2013384.","journal-title":"Nat Genet"},{"key":"BFejhg2012222_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00439-003-1025-2","volume":"114","author":"C Helmken","year":"2003","unstructured":"Helmken C, Hofmann Y, Schoenen F et al: Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1. Hum Genet 2003; 114: 11\u201321.","journal-title":"Hum Genet"},{"key":"BFejhg2012222_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/hmg\/9.2.259","volume":"9","author":"CL Lorson","year":"2000","unstructured":"Lorson CL, Androphy EJ : An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum Mol Genet 2000; 9: 259\u2013265.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2012222_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/978-3-540-34449-0_6","volume":"44","author":"B Wirth","year":"2006","unstructured":"Wirth B, Brichta L, Hahnen E : Spinal muscular atrophy and therapeutic prospects. Prog Mol Subcell Biol 2006; 44: 109\u2013132.","journal-title":"Prog Mol Subcell Biol"},{"key":"BFejhg2012222_CR16","doi-asserted-by":"publisher","first-page":"R111","DOI":"10.1093\/hmg\/ddq147","volume":"19","author":"CL Lorson","year":"2010","unstructured":"Lorson CL, Rindt H, Shababi M : Spinal muscular atrophy: mechanisms and therapeutic strategies. Hum Mol Genet 2010; 19: R111\u2013R118.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2012222_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s11940-009-0012-x","volume":"11","author":"BG Burnett","year":"2009","unstructured":"Burnett BG, Crawford TO, Sumner CJ : Emerging treatment options for spinal muscular atrophy. Curr Treat Options Neurol 2009; 11: 90\u2013101.","journal-title":"Curr Treat Options Neurol"},{"key":"BFejhg2012222_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature10485","volume":"478","author":"Y Hua","year":"2011","unstructured":"Hua Y, Sahashi K, Rigo F et al: Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature 2011; 478: 123\u2013126.","journal-title":"Nature"},{"key":"BFejhg2012222_CR19","doi-asserted-by":"crossref","unstructured":"Wadman RI, Bosboom WM, van den Berg LH, Wokke JH, Iannaccone ST, Vrancken AF : Drug treatment for spinal muscular atrophy types II and III. Cochrane Database Syst Rev 2011; 12 ( CD006282).","DOI":"10.1002\/14651858.CD006282.pub3"},{"key":"BFejhg2012222_CR20","doi-asserted-by":"crossref","unstructured":"Wadman RI, Bosboom WM, van den Berg LH, Wokke JH, Iannaccone ST, Vrancken AF : Drug treatment for spinal muscular atrophy type I. Cochrane Database Syst Rev 2011; 12 ( CD006281).","DOI":"10.1002\/14651858.CD006281.pub3"},{"key":"BFejhg2012222_CR21","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/ana.20836","volume":"59","author":"L Brichta","year":"2006","unstructured":"Brichta L, Holker I, Haug K, Klockgether T, Wirth B : In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate. Ann Neurol 2006; 59: 970\u2013975.","journal-title":"Ann Neurol"},{"key":"BFejhg2012222_CR22","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","volume":"12","author":"L Brichta","year":"2003","unstructured":"Brichta L, Hofmann Y, Hahnen E et al: Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. Hum Mol Genet 2003; 12: 2481\u20132489.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2012222_CR23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/ana.10743","volume":"54","author":"CJ Sumner","year":"2003","unstructured":"Sumner CJ, Huynh TN, Markowitz JA et al: Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann Neurol 2003; 54: 647\u2013654.","journal-title":"Ann Neurol"},{"key":"BFejhg2012222_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1471-4159.2006.03868.x","volume":"98","author":"E Hahnen","year":"2006","unstructured":"Hahnen E, Eyupoglu IY, Brichta L et al: In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy. J Neurochem 2006; 98: 193\u2013202.","journal-title":"J Neurochem"},{"key":"BFejhg2012222_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00439-006-0186-1","volume":"120","author":"M Riessland","year":"2006","unstructured":"Riessland M, Brichta L, Hahnen E, Wirth B : The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA\/protein levels in spinal muscular atrophy cells. Hum Genet 2006; 120: 101\u2013110.","journal-title":"Hum Genet"},{"key":"BFejhg2012222_CR26","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1093\/hmg\/ddp313","volume":"18","author":"L Garbes","year":"2009","unstructured":"Garbes L, Riessland M, Holker I et al: LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate. Hum Mol Genet 2009; 18: 3645\u20133658.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2012222_CR27","doi-asserted-by":"publisher","first-page":"9808","DOI":"10.1073\/pnas.171105098","volume":"98","author":"JG Chang","year":"2001","unstructured":"Chang JG, Hsieh-Li HM, Jong YJ, Wang NM, Tsai CH, Li H : Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci USA 2001; 98: 9808\u20139813.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg2012222_CR28","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/hmg\/ddi130","volume":"14","author":"LE Kernochan","year":"2005","unstructured":"Kernochan LE, Russo ML, Woodling NS et al: The role of histone acetylation in SMN gene expression. Hum Mol Genet 2005; 14: 1171\u20131182.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2012222_CR29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1172\/JCI29562","volume":"117","author":"AM Avila","year":"2007","unstructured":"Avila AM, Burnett BG, Taye AA et al: Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. J Clin Invest 2007; 117: 659\u2013671.","journal-title":"J Clin Invest"},{"key":"BFejhg2012222_CR30","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1093\/hmg\/ddq023","volume":"19","author":"M Riessland","year":"2010","unstructured":"Riessland M, Ackermann B, Forster A et al: SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy. Hum Mol Genet 2010; 19: 2154\u20132167.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2012222_CR31","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00109-008-0388-1","volume":"86","author":"LK Tsai","year":"2008","unstructured":"Tsai LK, Tsai MS, Ting CH, Li H : Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice. J Mol Med 2008; 86: 1243\u20131254.","journal-title":"J Mol Med"},{"key":"BFejhg2012222_CR32","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1136\/jnnp.2009.200253","volume":"82","author":"S Piepers","year":"2011","unstructured":"Piepers S, Cobben JM, Sodaar P et al: Quantification of SMN protein in leucocytes from spinal muscular atrophy patients: effects of treatment with valproic acid. J Neurol Neurosurg Psychiatry 2011; 82: 850\u2013852.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFejhg2012222_CR33","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1212\/01.wnl.0000231139.26253.d0","volume":"67","author":"CC Weihl","year":"2006","unstructured":"Weihl CC, Connolly AM, Pestronk A : Valproate may improve strength and function in patients with type III\/IV spinal muscle atrophy. Neurology 2006; 67: 500\u2013501.","journal-title":"Neurology"},{"key":"BFejhg2012222_CR34","doi-asserted-by":"publisher","first-page":"e21296","DOI":"10.1371\/journal.pone.0021296","volume":"6","author":"JT Kissel","year":"2011","unstructured":"Kissel JT, Scott CB, Reyna SP et al: SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy. PLoS One 2011; 6: e21296.","journal-title":"PLoS One"},{"key":"BFejhg2012222_CR35","doi-asserted-by":"publisher","first-page":"e12140","DOI":"10.1371\/journal.pone.0012140","volume":"5","author":"KJ Swoboda","year":"2011","unstructured":"Swoboda KJ, Scott CB, Crawford TO et al: SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy. PLoS One 2011; 5: e12140.","journal-title":"PLoS One"},{"key":"BFejhg2012222_CR36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.leukres.2009.07.024","volume":"34","author":"WG Tong","year":"2010","unstructured":"Tong WG, Wei Y, Stevenson W et al: Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor. Leuk Res 2010; 34: 221\u2013228.","journal-title":"Leuk Res"},{"key":"BFejhg2012222_CR37","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1038\/leu.2009.121","volume":"23","author":"S Deleu","year":"2009","unstructured":"Deleu S, Lemaire M, Arts J et al: The effects of JNJ-26481585, a novel hydroxamate-based histone deacetylase inhibitor, on the development of multiple myeloma in the 5T2MM and 5T33MM murine models. Leukemia 2009; 23: 1894\u20131903.","journal-title":"Leukemia"},{"key":"BFejhg2012222_CR38","doi-asserted-by":"publisher","first-page":"6841","DOI":"10.1158\/1078-0432.CCR-09-0547","volume":"15","author":"J Arts","year":"2009","unstructured":"Arts J, King P, Marien A et al: JNJ-26481585, a novel \u2018second-generation\u2019 oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity. Clin Cancer Res 2009; 15: 6841\u20136851.","journal-title":"Clin Cancer Res"},{"key":"BFejhg2012222_CR39","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1365-2141.2010.08126.x","volume":"149","author":"T Stuhmer","year":"2010","unstructured":"Stuhmer T, Arts J, Chatterjee M et al: Preclinical anti-myeloma activity of the novel HDAC-inhibitor JNJ-26481585. Br J Haematol 2010; 149: 529\u2013536.","journal-title":"Br J Haematol"},{"key":"BFejhg2012222_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/71709","volume":"24","author":"HM Hsieh-Li","year":"2000","unstructured":"Hsieh-Li HM, Chang JG, Jong YJ et al: A mouse model for spinal muscular atrophy. Nat Genet 2000; 24: 66\u201370.","journal-title":"Nat Genet"},{"key":"BFejhg2012222_CR41","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/ajmg.a.32233","volume":"146A","author":"LA Menke","year":"2008","unstructured":"Menke LA, Poll-The BT, Clur SA et al: Congenital heart defects in spinal muscular atrophy type I: a clinical report of two siblings and a review of the literature. Am J Med Genet A 2008; 146A: 740\u2013744.","journal-title":"Am J Med Genet A"},{"key":"BFejhg2012222_CR42","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1093\/hmg\/ddq330","volume":"19","author":"CR Heier","year":"2010","unstructured":"Heier CR, Satta R, Lutz C, DiDonato CJ : Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice. Hum Mol Genet 2010; 19: 3906\u20133918.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2012222_CR43","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1093\/hmg\/ddq329","volume":"19","author":"M Shababi","year":"2010","unstructured":"Shababi M, Habibi J, Yang HT, Vale SM, Sewell WA, Lorson CL : Cardiac defects contribute to the pathology of spinal muscular atrophy models. Hum Mol Genet 2010; 19: 4059\u20134071.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2012222_CR44","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/jmg.2008.057950","volume":"45","author":"S Rudnik-Schoneborn","year":"2008","unstructured":"Rudnik-Schoneborn S, Heller R, Berg C et al: Congenital heart disease is a feature of severe infantile spinal muscular atrophy. J Med Genet 2008; 45: 635\u2013638.","journal-title":"J Med Genet"},{"key":"BFejhg2012222_CR45","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1093\/hmg\/ddr360","volume":"20","author":"CA Mutsaers","year":"2011","unstructured":"Mutsaers CA, Wishart TM, Lamont DJ et al: Reversible molecular pathology of skeletal muscle in spinal muscular atrophy. Hum Mol Genet 2011; 20: 4334\u20134344.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2012222_CR46","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.nmd.2011.10.021","volume":"22","author":"E Somers","year":"2012","unstructured":"Somers E, Stencel Z, Wishart TM, Gillingwater TH, Parson SH : Density, calibre and ramification of muscle capillaries are altered in a mouse model of severe spinal muscular atrophy. Neuromuscul Disord 2012; 22: 435\u2013442.","journal-title":"Neuromuscul Disord"},{"key":"BFejhg2012222_CR47","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1093\/hmg\/ddq094","volume":"19","author":"Y Mende","year":"2010","unstructured":"Mende Y, Jakubik M, Riessland M et al: Deficiency of the splicing factor Sfrs10 results in early embryonic lethality in mice and has no impact on full-length SMN\/Smn splicing. Hum Mol Genet 2010; 19: 2154\u20132167.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2012222_CR48","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.expneurol.2008.02.025","volume":"212","author":"BF El-Khodor","year":"2008","unstructured":"El-Khodor BF, Edgar N, Chen A et al: Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophy. Exp Neurol 2008; 212: 29\u201343.","journal-title":"Exp Neurol"},{"key":"BFejhg2012222_CR49","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/hmg\/ddm367","volume":"17","author":"LM Murray","year":"2008","unstructured":"Murray LM, Comley LH, Thomson D, Parkinson N, Talbot K, Gillingwater TH : Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum Mol Genet 2008; 17: 949\u2013962.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2012222_CR50","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/hmg\/ddn357","volume":"18","author":"J Hauke","year":"2009","unstructured":"Hauke J, Riessland M, Lunke S et al: Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition. Hum Mol Genet 2009; 18: 304\u2013317.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2012222_CR51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/onc.2009.306","volume":"29","author":"E Borbone","year":"2012","unstructured":"Borbone E, Berlingieri MT, De Bellis F et al: Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation. Oncogene 2012; 29: 105\u2013116.","journal-title":"Oncogene"},{"key":"BFejhg2012222_CR52","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.biopha.2011.06.007","volume":"66","author":"A Yeung","year":"2010","unstructured":"Yeung A, Bhargava RK, Ahn R et al: HDAC inhibitor M344 suppresses MCF-7 breast cancer cell proliferation. Biomed Pharmacother 2010; 66: 232\u2013236.","journal-title":"Biomed Pharmacother"},{"key":"BFejhg2012222_CR53","doi-asserted-by":"publisher","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","volume":"3","author":"MA Passini","year":"2011","unstructured":"Passini MA, Bu J, Richards AM et al: Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy. Sci Transl Med 2011; 3: 72ra18.","journal-title":"Sci Transl Med"},{"key":"BFejhg2012222_CR54","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.nmd.2011.09.007","volume":"22","author":"M Bowerman","year":"2012","unstructured":"Bowerman M, Murray LM, Beauvais A, Pinheiro B, Kothary R : A critical Smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology. Neuromuscul Disord 2012; 22: 263\u2013276.","journal-title":"Neuromuscul Disord"},{"key":"BFejhg2012222_CR55","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/hmg\/ddp506","volume":"19","author":"LM Murray","year":"2010","unstructured":"Murray LM, Lee S, Baumer D, Parson SH, Talbot K, Gillingwater TH : Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy. Hum Mol Genet 2010; 19: 420\u2013433.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2012222_CR56","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1093\/hmg\/ddr600","volume":"21","author":"PN Porensky","year":"2012","unstructured":"Porensky PN, Mitrpant C, McGovern VL et al: A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse. Hum Mol Genet 2012; 21: 1625\u20131638.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2012222_CR57","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1101\/gad.197418.112","volume":"26","author":"K Sahashi","year":"2012","unstructured":"Sahashi K, Hua Y, Ling KK et al: TSUNAMI: an antisense method to phenocopy splicing-associated diseases in animals. Genes Dev 2012; 26: 1874\u20131884.","journal-title":"Genes Dev"},{"key":"BFejhg2012222_CR58","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.cmet.2011.03.020","volume":"13","author":"SD Kunkel","year":"2011","unstructured":"Kunkel SD, Suneja M, Ebert SM et al: mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass. Cell Metab 2011; 13: 627\u2013638.","journal-title":"Cell Metab"},{"key":"BFejhg2012222_CR59","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1093\/hmg\/ddr067","volume":"20","author":"M Bosch-Marce","year":"2011","unstructured":"Bosch-Marce M, Wee CD, Martinez TL et al: Increased IGF-1 in muscle modulates the phenotype of severe SMA mice. Hum Mol Genet 2011; 20: 1844\u20131853.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2012222_CR60","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1177\/0883073807304009","volume":"22","author":"N Yuan","year":"2007","unstructured":"Yuan N, Wang CH, Trela A, Albanese CT : Laparoscopic Nissen fundoplication during gastrostomy tube placement and noninvasive ventilation may improve survival in type I and severe type II spinal muscular atrophy. J Child Neurol 2007; 22: 727\u2013731.","journal-title":"J Child Neurol"},{"key":"BFejhg2012222_CR61","first-page":"475","volume":"74","author":"D Karasick","year":"1982","unstructured":"Karasick D, Karasick S, Mapp E : Gastrointestinal radiologic manifestations of proximal spinal muscular atrophy (Kugelberg-Welander syndrome). J Natl Med Assoc 1982; 74: 475\u2013478.","journal-title":"J Natl Med Assoc"},{"key":"BFejhg2012222_CR62","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/mus.880170816","volume":"17","author":"V Ionasescu","year":"1994","unstructured":"Ionasescu V, Christensen J, Hart M : Intestinal pseudo-obstruction in adult spinal muscular atrophy. Muscle Nerve 1994; 17: 946\u2013948.","journal-title":"Muscle Nerve"},{"key":"BFejhg2012222_CR63","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/SPC.0b013e3282f31667","volume":"1","author":"M Lainscak","year":"2007","unstructured":"Lainscak M, Podbregar M, Anker SD : How does cachexia influence survival in cancer, heart failure and other chronic diseases? Curr Opin Support Palliat Care 2007; 1: 299\u2013305.","journal-title":"Curr Opin Support Palliat Care"},{"key":"BFejhg2012222_CR64","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1093\/hmg\/ddq300","volume":"19","author":"AK Bevan","year":"2010","unstructured":"Bevan AK, Hutchinson KR, Foust KD et al: Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery. Hum Mol Genet 2010; 19: 3895\u20133905.","journal-title":"Hum Mol Genet"},{"key":"BFejhg2012222_CR65","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1540-8167.2008.01327.x","volume":"20","author":"M Roos","year":"2009","unstructured":"Roos M, Sarkozy A, Chierchia GB, De Wilde P, Schmedding E, Brugada P : Malignant ventricular arrhythmia in a case of adult onset of spinal muscular atrophy (Kugelberg-Welander disease). J Cardiovasc Electrophysiol 2009; 20: 342\u2013344.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"BFejhg2012222_CR66","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/00000441-200612000-00009","volume":"332","author":"N Takahashi","year":"2006","unstructured":"Takahashi N, Shimada T, Ishibashi Y et al: Cardiac involvement in Kugelberg-Welander disease: a case report and review. Am J Med Sci 2006; 332: 354\u2013356.","journal-title":"Am J Med Sci"},{"key":"BFejhg2012222_CR67","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/0883073807299954","volume":"22","author":"E Vaidla","year":"2007","unstructured":"Vaidla E, Talvik I, Kulla A et al: Neonatal spinal muscular atrophy type 1 with bone fractures and heart defect. J Child Neurol 2007; 22: 67\u201370.","journal-title":"J Child Neurol"},{"key":"BFejhg2012222_CR68","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1146\/annurev.neuro.28.061604.135659","volume":"28","author":"NO Glebova","year":"2005","unstructured":"Glebova NO, Ginty DD : Growth and survival signals controlling sympathetic nervous system development. Annu Rev Neurosci 2005; 28: 191\u2013222.","journal-title":"Annu Rev Neurosci"},{"key":"BFejhg2012222_CR69","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0896-6273(02)00774-2","volume":"35","author":"Y Honma","year":"2002","unstructured":"Honma Y, Araki T, Gianino S et al: Artemin is a vascular-derived neurotropic factor for developing sympathetic neurons. Neuron 2002; 35: 267\u2013282.","journal-title":"Neuron"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg2012222.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2012222","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2012222.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:06:41Z","timestamp":1684429601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg2012222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,17]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["BFejhg2012222"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2012.222","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,17]]}}}